aTyr Pharma (ATYR)

• Market cap: $45.6M
• 1 day: 3.24%
• 5 days: -0.79%
• 1 month: -5.08%
• 3 months: -43.79%
• 6 months: -35.93%
• Year to date: -38.73%
• 1 year: -90.66%
• 5 years: -89.48%
• 10 years: -98.81%
• Sector: Healthcare
• Industry: Biotechnology

About: aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).

Employees: 58